发明名称 3-methyl-2- ( (2S) -2- (4- (3-methyl-L, 2, 4-oxadiazol-5-YL) phenyl) morpholino) -6- (pyrim-idin-4-yl) pyrimidin-4 (3H) -one as tau protein kinase inhibitor
摘要 A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g. Alzheimer disease).
申请公布号 US8288383(B2) 申请公布日期 2012.10.16
申请号 US20080677161 申请日期 2008.09.12
申请人 SAKAI DAIKI;WATANABE KAZUTOSHI;SANOFI 发明人 SAKAI DAIKI;WATANABE KAZUTOSHI
分类号 A61K31/535;C07D413/14 主分类号 A61K31/535
代理机构 代理人
主权项
地址